RA
CC icon

Rise Advisors’s Chemours CC Stock Holding History

Rise Advisors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-583
Closed -$9.23K – 321
2025
Q3 		$9.23K Sell
583
-74
-11% -$1.07K ﹤0.01% 1029
2025
Q2 		$7.52K Buy
657
+19
+3% +$214 ﹤0.01% 1120
2025
Q1 		$8.63K Buy
638
+73
+13% +$1.21K ﹤0.01% 1078
2024
Q4 		$9.55K Sell
565
-2
-0.4% -$39 ﹤0.01% 991
2024
Q3 		$11.5K Buy
567
+8
+1% +$164 0.01% 975
2024
Q2 		$12.6K Buy
559
+6
+1% +$157 0.01% 913
2024
Q1 		$14.5K Buy
553
+544
+6,044% +$15.5K 0.01% 873
2023
Q4 		$281 Hold
9
– – ﹤0.01% 587
2023
Q3 		$248 Hold
9
– – ﹤0.01% 608
2023
Q2 		$323 Hold
9
– – ﹤0.01% 639
2023
Q1 		$261 Hold
9
– – ﹤0.01% 774
2022
Q4 		$264 Hold
9
– – ﹤0.01% 732
2022
Q3 		$0 Hold
9
– – ﹤0.01% 711
2022
Q2 		$0 Buy
9
+1
+13% +$37 ﹤0.01% 708
2022
Q1 		$0 Hold
8
– – ﹤0.01% 657
2021
Q4 		$281 Buy
+8
New +$249 ﹤0.01% 636

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rise Advisors's CC Position: Q4 2025 in Review

Rise Advisors sold out of Chemours (CC) in Q4 2025, closing a stake of 583 shares — an estimated $9.23K sold.

Rise Advisors first reported a position in CC in Q4 2021 and held it in 16 quarters. The position peaked at $14.5K in Q1 2024. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Rise Advisors reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 583 Chemours shares in Q4 2025, an estimated $9.23K.
  • Rise Advisors first reported a position in Chemours in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Chemours position peaked at $14.5K in Q1 2024.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.